News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
India launches Swasth Bharat Portal to unify health apps
New government platform consolidates multiple siloed health systems used by frontline workers into a single interface with shared data.
AI triples cancer detection speed, beats doctors in ER diagnosis
Mayo Clinic's REDMOD detects pancreatic cancer 36 months early while OpenAI's o1 outperformed physicians on emergency room cases by wide margins.
Healthcare AI needs data infrastructure first, says HIMSS
Event promoters argue analytics foundation must precede AI implementation, but provide no supporting evidence or methodology.
EHR consolidation story lacks substance beyond event promotion
Healthcare IT News article reduces to conference marketing copy with no actual data on market consolidation effects.
Medtronic data breach hits unknown volume of corporate files
ShinyHunters group allegedly exploited Salesforce platform weakness to access medical device giant's systems, though patient tech unaffected.
Roche buys PathAI for $1.05B to scale digital pathology AI
Swiss pharma giant acquires Boston AI firm to combine digital pathology tools with oncology diagnostics globally.
Entrada stock drops 50% on weak Duchenne trial data
Biotech's Phase 1/2 Duchenne muscular dystrophy study results fell short of analyst expectations despite company claims of success.
Angelini pays $4.1B for Catalyst's rare neuro drug portfolio
Italian pharma buys US biotech with $589M revenue run rate from three CNS medicines, gaining direct access to American market.
Amgen adds $300M to Puerto Rico biologics production
The biotech giant expands its Juncos facility investment as manufacturing shifts continue across the sector.
Entrada Duchenne drug data disappoints in six patients
Biotech's exon 44 skipping therapy shows initial results in low-dose cohort, sending shares lower on investor concerns.
Blackstone backs Anagram with $250M for cystic fibrosis treatment
Private equity giant commits to biotech developing therapy for CF complication affecting thousands of patients annually.
Health insurers cut 2025 profit forecasts amid rising medical costs
Multiple major health insurance companies withdrew or reduced earnings guidance as medical expense claims exceeded expectations.